| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |